Jason Naziri

Radiation Oncology

2401 S 31st St
Temple, TX 76508

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation.

C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation.

Journal: Cureus

Published: November 12, 2021

Showing 1-1 of 1

Last Updated: 09/26/2026